The trial met its primary endpoint with a hazard ratio of 0.75, indicating a significant reduction in disease progression ...

Gender and ethnic disparities in breast cancer and cardiovascular disease-related mortality in United States from 1999-2019: A retrospective analysis. This is an ASCO Meeting Abstract from the 2025 ...

In this analysis from the phase 3 S1826 study, researchers aimed to show the durability of the efficacy of nivolumab plus doxorubicin, vinblastine, and dacarbazine in classic Hodgkin lymphoma.

Stage 3 Hodgkin’s lymphoma either indicates lymphoma in the lymph nodes both above and below a person’s diaphragm or in the lymph nodes above the diaphragm and in the spleen. Doctors may also refer to ...

A study published in the Journal of Clinical Oncology confirms that one of the first Food and Drug Administration-approved CAR-T cell therapies offers long-term survival and potential cures for adult ...